Activist defends fintech Temenos after Hindenburg report Date Friday, February 16, 2024 - 12:04 PM Description Petrus Advisers disputes short seller’s report after Swiss group’s shares plunge
Activist Elliott goes after SoftBank Date Wednesday, June 05, 2024 - 10:00 PM Description Plus, De Beers unveils plan to counter lab-grown diamonds and the cloud-computing company riding Nvidia’s coattails
Activist fund targets Japan rail company with $12bn stake in Tokyo Disneyland owner Date Tuesday, October 17, 2023 - 2:51 AM Description Palliser’s campaign comes as companies are under intensifying pressure to raise corporate value
Activist investor builds stake in Reckitt after baby formula verdict Date Monday, May 20, 2024 - 10:00 PM Description Eminence Capital began buying shares in March when they were hit by a $60mn US damages award
Activist investor Cevian records 20% gain boosted by CRH relisting Date Monday, December 11, 2023 - 7:47 AM Description Fund returns this year beat MSCI Europe index, also lifted by performance of Rexel and ABB
Activist investor Jeff Ubben to join Bayer’s supervisory board Date Thursday, February 29, 2024 - 11:44 AM Description Struggling German chemicals group announces boardroom reshuffle ahead of update on potential break-up
Activist investors mount record number of attacks against companies Date Saturday, January 06, 2024 - 9:03 AM Description More shareholders are picking proxy fights with businesses whose stock prices have languished
Activist pushes for end of Murdoch voting control at News Corp Date Monday, September 09, 2024 - 10:44 AM Description Family shareholdings at media conglomerate under fresh scrutiny as Rupert Murdoch seeks to transfer power to son
Activist shareholders target Samsung to unlock value Image Date Thursday, February 01, 2024 - 10:02 PM Description Investors in South Korea emboldened by Japan’s corporate governance drive
Activists should want reconstructive surgery at Smith & Nephew Date Thursday, July 04, 2024 - 8:28 AM Description A spinout of the medtech’s orthopaedics business would unlock value while shifting to the US could also deliver gains